Good Manufacturing Practices (GMP) on FDA regulatory agenda
This article was originally published in Clinica
Executive Summary
The final revised US GMPs for medical devices are due to be published in September this year, according to the FDA regulatory agenda. Other outstanding regulations to implement the 1990 Safe Medical Devices Act which will be introduced in the next five months include: procedures for a hearing before imposition of civil money penalties; premarket review exemption for humanitarian devices; procedures for using the FDA's device recall authority; requirement for healthcare facilities and distributors to report deaths and serious injuries/illnesses related to devices; procedures for manufacturers to report to the FDA health-related removals and corrections of devices; and procedures for temporary suspension of a PMA application.
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.